Gotham Asset Management, LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1510387
NEW YORK, NY
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,564,210
-$1,415,178 QoQ
Shares Held
156,421
-50.0% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#102
of 318 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $248,215,917 across 22 Drug Manufacturers - Specialty & Generic names. BCRX ranks #11 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
4,374,683 | $69,469,966 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
371,568 | $62,624,070 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
79,123 | $42,871,215 | |
| 4 | ZTS |
Zoetis Inc.
|
531,415 | $38,187,481 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
465,714 | $11,461,221 | |
| 6 | PRGO |
PERRIGO Co plc
|
435,648 | $4,526,382 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
94,850 | $3,891,695 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
76,441 | $2,767,164 |
All Filings in BCRX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,564,210 | 156,421 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,979,388 | 312,961 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,692,178 | 216,946 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,609,221 | 343,771 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,808,244 | 201,813 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $330,480 | 44,064 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $295,586 | 38,893 | Shares | Sole | 2024-11-14 | |
| 2023-09-30 | $488,753 | 69,033 | Shares | Sole | 2023-11-14 | |
| 2022-09-30 | $302,828 | 24,034 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $236,550 | 14,548 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $156,615 | 11,308 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $769,014 | 48,641 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $109,202 | 14,658 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $48,036 | 13,964 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $72,066 | 15,140 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $56,736 | 28,368 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||